BioCentury
ARTICLE | Emerging Company Profile

ProFibrix: Hemostatic sprinkles

March 26, 2007 7:00 AM UTC

The market for hemostatic products is getting increasingly crowded. But so far these products are sold primarily as powders or frozen liquid, both of which must be prepared for use in liquid form. Since severe bleeding can be an unexpected event, ProFibrix B.V. thinks its Fibrocaps dry powder fibrin sealant may have a competitive advantage, since it can be used off the shelf as a powder without rehydrating.

On Monday this week, the company was expected to announce an E8.5 million ($11 million) series A round...